set reports all direct and indirect (ie, disbursed to an affiliated organization) payments provided to physician principal investigators by drug and device manufacturers for research activities, such as clinical study coordination and scientific writing, between January 1, 2015, and December 31, 2015. We excluded individual payments with more than 1 principal investigator from analysis, which accounted for less than .05% of the total value.
After identifying the specialty of each principal investigator, we performed descriptive analyses for each surgical specialty to determine the following: (1) proportion of compensated surgeons; (2) mean and median payment per compensated surgeon; (3) total payment per specialty; and (4) payment type (cash or equivalent/in-kind items and services). The number of active surgeons in each specialty was obtained from the Association of American Medical Colleges 2014 Physician Specialty Databook. For otolaryngology, the total research payment attributable to each sponsor was tabulated and descriptive analysis was performed.
Results | In 2015, drug and device manufacturers provided 2933 payments worth $8 355 091 to 171 otolaryngologists. Payment was primarily provided as cash or equivalent (89.0%), with the remainder provided as in-kind items or services (11.0%), such as donated study equipment. The mean payment per compensated otolaryngologist ($48 860) was nearly 10-fold greater than the median ($5096; 10th-90th percentile, $169-$102 900), indicating that a small number of top earners were compensated well above the median and accounted for a disproportionately large share of payment to otolaryngologists (ie, positive skew). The top 15 highest-paying industry sponsors accounted for the large majority (84.8%) of payment value and featured manufacturers with products indicated for sinonasal and otologic conditions ( Figure) .
Among surgical specialties, otolaryngology had the secondlowest proportion of compensated surgeons (1.83%), which was approximately 6-fold lower than the highest proportion (vascular, 11.34%). In addition, otolaryngology had the second lowest median payment per compensated surgeon, which was nearly 4-fold lower than the highest payment (ophthalmology, $19 487; 10th-90th percentile, $2318-$156 724). Positive skew owing to top earners and predominance of cash payments were present across all surgical specialties (Table) .
Discussion | Health care industry sponsorship of research in otolaryngology was limited to a small number of surgeons. In addition, otolaryngologists generally received less research payment than other surgeons. These findings are consistent with prior work examining nonresearch payments to otolaryngologists and suggest less potential for bias in the literature and practice of otolaryngology. 4 Given formidable competition for federal funding to investigate otolaryngologic diseases, 5 the health care industry may serve as an important resource for otolaryngologists. At present, our findings indicate that industry funding is concentrated among a subset of top earners funded by manufacturers with products indicated for sinonasal and otologic conditions. Patients may The "All Other" category includes payments provided to otolaryngologists by all other health care industry sponsors.
benefit from more diverse collaborations between otolaryngologists and the health care industry, particularly in emerging disciplines such as sleep medicine and laryngology. 6 This study has limitations. It is certain that the findings underestimate the extent of industry support, as manufacturers are permitted to delay the publication of research payments related to products under development or novel applications of existing products. In addition, analyses provide limited context to understand the nature of research activities. Additional investigation is necessary to understand the promise and pitfalls of industry collaborations in otolaryngology.
Surgeon Volume in Parathyroid SurgerySurgical Efficiency, Outcomes, and Utilization
Surgery is the standard of care for primary hyperparathyroidism, with US surgeons annually performing an estimated 17 000 parathyroidectomies. 1 Although a well-documented association between higher surgeon volume and better outcomes exists for thyroid surgery, 2,3 a single study 4 examines 
